Login / Signup

Metformin in Combination with Standard Therapy in Patients with Diffuse Large B-Cell Lymphoma: A Randomized Phase II Clinical Trial.

Amira HegazyManar Salaheldin AliNabil Ahmed MubarakHagar Abdel Magied AlagizyAhmed Sohaib
Published in: Asian Pacific journal of cancer prevention : APJCP (2024)
The addition of metformin to standard R-CHOP could improve clinical outcomes in patients with DLBCL with a tolerable safety profile.
Keyphrases
  • diffuse large b cell lymphoma
  • phase ii
  • clinical trial
  • open label
  • epstein barr virus
  • phase iii
  • double blind
  • placebo controlled
  • randomized controlled trial